Insider filing · AXSM
Mark Coleman
Director
profile →
Axsome Therapeutics, Inc.
AXSM · Healthcare · 34 filings in 24 months
ticker →
Mark Coleman sold $322K of Axsome Therapeutics (AXSM)
Executed May 20 2025, disclosed May 20 2025, the same day.
Value, as filed
$322K
3,000 sh × $107.49
Executed
May 20 2025
the trade date, as filed
Disclosed
May 20 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MCMark Coleman (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Axsome Therapeutics, Inc. (AXSM). The largest single filing was $4.0M of AXSM (25,000 sh × $161.11, as filed), executed Feb 26.
The name
AXSMHealthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mark Coleman in AXSM
AXSMSALE
Axsome Therapeutics, Inc.
$160K643 sh × $249.00
Exec Jun 10
Filed Jun 10 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $4.0M
17,537 sh across 3 lots
Exec May 29
Filed Jun 2 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $4.0M
25,000 sh × $161.11
Exec Feb 26
Filed Feb 27 · 5:30 PM ET AXSMPURCHASE Axsome Therapeutics, Inc. $102K
800 sh × $127.20
Exec Sep 8 2025
Filed Sep 9 2025 · 8:11 PM ET AXSMSALE Axsome Therapeutics, Inc. $783K
7,500 sh across 2 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET